346 related articles for article (PubMed ID: 4386815)
1. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
[No Abstract] [Full Text] [Related]
2. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
[TBL] [Abstract][Full Text] [Related]
3. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
Niemegeers CJ; Janssen PA
Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
[No Abstract] [Full Text] [Related]
4. Pharmacology and biochemistry of haloperidol.
Niemegeers CJ; Laduron PM
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
[No Abstract] [Full Text] [Related]
5. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].
Mikhaĭlova TV; Terekhina AI; Gilev AP
Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895
[No Abstract] [Full Text] [Related]
6. The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Verbruggen FJ; van Nueten JM; Marsboom RH; Hérin VV; Schaper WK
Arzneimittelforschung; 1970 Nov; 20(11):1689-98. PubMed ID: 4992598
[No Abstract] [Full Text] [Related]
7. The neuroleptics. 3. Pharmacology. Introduction.
Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
[No Abstract] [Full Text] [Related]
8. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
[No Abstract] [Full Text] [Related]
9. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. 3. Regional distribution of pimozide and of haloperidol in the dog brain.
Janssen PA; Soudijn W; van Wijngaarden I; Dresse A
Arzneimittelforschung; 1968 Mar; 18(3):282-7. PubMed ID: 5696000
[No Abstract] [Full Text] [Related]
10. [Pharmacological studies on psychotropic drugs especially the effects of thiothixene].
Shibuya T; Horibe M; Sasaki Y; Matsuda H; Matsumiya T
Zasshi Tokyo Ika Daigaku; 1969 Nov; 27(6):839-57. PubMed ID: 4396402
[No Abstract] [Full Text] [Related]
11. Chemical and pharmacological classification of neuroleptics.
Janssen PA
Mod Probl Pharmacopsychiatry; 1970; 5():33-44. PubMed ID: 5535847
[No Abstract] [Full Text] [Related]
12. [Pharmacological studies of an antipschotic agent, penfluridol. (1). The central pharmacological actions].
Ito K; Nurimoto S; Shintomi K; Kowa Y; Yamamura M; Ishida R
Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):795-813. PubMed ID: 828132
[TBL] [Abstract][Full Text] [Related]
13. [Neurotropic properties of fluphenazine].
Liubimov BI; Raevskiĭ KS; Ostrovskaia RU; Barkov NK; Krolevets GN
Farmakol Toksikol; 1971; 34(3):287-90. PubMed ID: 5106035
[No Abstract] [Full Text] [Related]
14. Pharmacological and toxicological studies on gamma-(4-methylpiperidino)-p-fluorobutyrophenone (FG 5111)--a new neuroleptic agent.
Christensen JA; Hernestam S; Lassen JB; Sterner N
Acta Pharmacol Toxicol (Copenh); 1965; 23(2):109-32. PubMed ID: 5899275
[No Abstract] [Full Text] [Related]
15. Pharmacology and biochemistry of bromperidol.
Niemegeers CJ; Laduron PM; Janssen PA
Acta Psychiatr Belg; 1978; 78(1):37-50. PubMed ID: 645406
[No Abstract] [Full Text] [Related]
16. [Central effects of some adreno- and-or sympatholytic substances. 3. Ptosis, catalepsy, antagonism with respect to apomorphine and amphetamine].
Boissier JR; Simon P; Giudicelli JF
Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):68-80. PubMed ID: 5689547
[No Abstract] [Full Text] [Related]
17. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. IV. Antiadrenergic action and influence on brain monoamines.
Dlabac A; Metys J; Metysová J
Act Nerv Super (Praha); 1971; 13(3):188-9. PubMed ID: 5113833
[No Abstract] [Full Text] [Related]
18. [Antagonism of the effect of dopamine and norepinephrine on some isolated organs].
Ferrini R; Miragoli G
Boll Soc Ital Biol Sper; 1973 Jul; 49(11):648-52. PubMed ID: 4799566
[No Abstract] [Full Text] [Related]
19. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
Vetulani J
Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
[No Abstract] [Full Text] [Related]
20. On the interaction between neuroleptics and antiparkinson drugs.
Julou L
Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
